Newborns with major congenital malformations (MCM) have contributed to a significant proportion of resource utilization in a regional referral neonatal intensive care unit (NICU).
Congenital malformations remain the leading cause of deaths in the United States for infants less than 1 year of age, with sudden infant death syndrome and disorders of prematurity being close behind. 1 Recently, advances in the care of premature infants, including antenatal steroids and surfactant therapy, have resulted in improved survival for this neonatal intensive care unit (NICU) population. Concurrently, newborns with major congenital malformations (MCM) have contributed to a consistent and relatively higher proportion of total NICU deaths than other hospitalized NICU patients. 2 Difficult decisions involving the provision of care for newborns with malformations were the basis for the development of the "Baby Doe" rulings by the U.S. Department of Health and Human Services in 1985. The regulations placed increasing responsibility on pediatricians to treat all infants with congenital malformations by requiring that reasonable measures be done to preserve the life of an infant with a serious condition. 3, 4 Today, ethical considerations remain an integral part of the care of newborns with malformations.
The combination of recent advancements in neonatal care and the responsibility to treat infants with life-threatening conditions may lead to an increased contribution to hospital resource use by newborns with major congenital malformations admitted to a regionalized NICU. In this study, we examined resource utilization in a population of infants with MCM admitted to a single referral children's hospital NICU over a 1-year time period. The comparison population consisted of newborns without MCM (non-MCM) admitted to the same NICU during the same time period.
We hypothesized that newborns with MCMs would contribute significantly ( p Ͻ 0.05) to the median cost and median length of the initial hospitalization compared with those without MCMs. The purpose of the study was (1) to determine the duration and cost of the initial NICU hospitalization for newborn infants with MCM compared with non-MCM patients admitted to the same referral NICU and (2) to assess the extent of ongoing medical supportive care received by infants with MCM at the time of initial hospital discharge.
MATERIALS AND METHODS

Patient Selection
Patients with MCM were selected from the total number of regional newborns admitted to Children's Hospital Medical Center in Cincinnati, OH during the time period of August 1, 1993 through July 31, 1994. For the purpose of the study, MCM were defined as malformations involving the central nervous, cardiovascular, respiratory, gastrointestinal, or genitourinary systems, which necessitated the use of intensive care resources, including mechanical ventilation, cardiorespiratory monitoring, continuous infusions, surgical or other subspecialty consultation, or intravenous or enteral nutritional support. The
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non-MCM group consisted of all regional newborns with diagnoses other than a major congenital malformation admitted to Children's Hospital over the same time period. Regional newborns were defined as newborn infants born at hospitals incorporated into the established regionalized system for perinatal care in southwest Ohio, southeast Indiana, and northwest Kentucky.
Data Collection
Institutional Review Board approval was obtained for chart and computerized review. A computer-generated list of infants admitted between August 1, 1993 and July 31, 1994 to Children's Hospital NICU with a congenital malformation diagnostic code was obtained from the neonatal database, which contains information on all newborns born in the previously described region. During the time period of this study, the database used the Hospital International Classification of Disease Adapted (HICDA) coding system, a precursor to the current ICD9-CM. The computer identified all patients with HICDA codes 74 to 75, which designate congenital malformations, for the search. The diagnoses of patients excluded from the MCM group are shown in Table 1 . These patients were assigned to the non-MCM group along with other regional patients without MCM admitted during the same period. All admitted patients born outside the previously described referral region were excluded. Patients assigned a malformation code inappropriately were also excluded through review of the computer list.
Regional Statistics
Regional statistics were obtained through the computerized neonatal database for the time period under study. They included the number of live births, rates of neonatal deaths, lethal malformations, NICU admissions, and the incidence of NICU mortality for the Children's Hospital.
Perinatal Variables
Perinatal data obtained for the MCM and non-MCM groups included maternal age and parity; birth weight; gestational age by examination; and the site of delivery, i.e., Level I, Level II, or Level III hospital.
Primary Outcomes
The primary outcomes were measures of NICU resource use, including total and median length of NICU stay in days and total and median cost in dollars during the initial admission for patients with and without MCM. Information on the cost of hospitalization was generated from the hospital cost accounting system and adjusted to 1995 dollars. Costs obtained reflect only hospital days spent in the NICU. For all patients in the final MCM inclusion group, physician and nursing discharge summaries and home health referrals were reviewed to assess the need and provision of ongoing medical support at discharge. Medical support data were collected for three broad categories of resource use post-discharge: use of oxygen and/or mechanical respiratory support, use of supplemental feeding regimens, and use of home nursing services. For the MCM group, surgical procedure codes were recorded from patient records to determine the incidence of major surgical procedures, defined as procedures utilizing intravenous and general endotracheal anesthesia and/or cardiopulmonary bypass.
Data Analysis
A computerized data analysis system (SAS) was used to perform statistical analysis. We utilized chi-squared and two-tailed t tests to analyze the perinatal variables between populations. The Wilcoxon rank sum analysis was used for the distributions of length of stay and cost.
RESULTS
Sample Population
The initial number of malformation patients retrieved by computer search was 260. Of these, 152 met inclusion criteria. Forty of the 260 were excluded due to birth outside the region. Forty-nine were excluded from the malformation group because of the presence of only minor malformations, including patent foramen ovale (PFO), isolated ventricular septal defect (VSD), isolated hypospadias, polydactyly, syndactyly, nonsyndromic cleft lip or palate, and facial anomaly. Nineteen were excluded due to inappropriate assignment of a malformation code (extracorporeal membrane oxygenation patients, 16; pneumomediastinum, 2; colonic stricture secondary to NEC, 1). Of the 152 patients meeting inclusion criteria, five patient records were unavailable for review. The final number of patients included in the MCM group was 147. From the region admitted to the Children's Hospital NICU, 385 patients were included in the non-MCM group during the time period studied.
Regional Statistics
Over the 1-year period between August 1, 1993 and July 31, 1994, there were 28,967 live births and 154 neonatal deaths in the region. The regional lethal malformation rate was stable over the 10-year Table  2 . The NICU admission rate for the period was 20.0 per 1000 live births. The mortality rate for the initial NICU hospitalization was 6.1% (9 of 147) for the MCM group and 4.1% (18 of 385) for the non-MCM group (not statistically significant by chi-squared test).
Perinatal Variables
As shown in Table 3 , there was no statistically significant difference between MCM and non-MCM groups in maternal age or parity ( p ϭ 0.08 and 0.06, respectively). The birth weights of MCM patients were heavier on average and the mean gestational age was greater compared with non-MCM patients ( p ϭ 0.0001). The distribution of level of hospital of birth was significantly different between the two groups, with a higher percentage of MCM patients born in level III hospitals than non-MCM patients ( p ϭ 0.0001 by chi-square). Table 4 shows the primary outcomes for the two populations. Patients with MCM accounted for 27.6% of NICU referrals, 32.4% of total NICU days, and 39.6% of NICU costs. The median length of stay was 16 days in the MCM group (n ϭ 147) compared with 9 days in the non-MCM group (n ϭ 385). This difference was statistically significant ( p ϭ 0.0001). The median cost per patient was also significantly higher in MCM than non-MCM patients ($24,655 vs $12,339) ( p ϭ 0.0001). We sought to further evaluate the significant length of stay and cost differences between groups by subdividing both groups based on whether or not a major surgical procedure was performed. Patients in the MCM group had a significantly higher incidence of major surgical procedures (74%) than non-MCM patients (22%) ( p Ͻ 0.01 by chisquared test, data not shown). The most common surgical procedures performed on patients with malformations (excluding central access and circumcision) were gastrostomy, cystoscopy, systemic to pulmonary shunt, repair of imperforate anus, atrial septostomy, transposi- *Score Ն1. †Score Ն1 Ͻ 5. Respiratory: 0 ϭ no oxygen requirement, 1 ϭ nasal cannula oxygen, 2 ϭ tracheostomy, 3 ϭ positive pressure ventilation. Nutrition: 0 ϭ full oral feeding, 1 ϭ tube supplementation, 2 ϭ tube feedings for Ͼ50% of caloric intake, 3 ϭ full tube feedings or parenteral feedings. Nursing services: 0 ϭ no services required, 1 ϭ intermittent home nurse visits, 2 ϭ home nursing 1 to 12 hours/day, 3 ϭ home nursing 12 to 24 hours/day, 4 ϭ convalescent care facility, 5 ϭ unknown or not applicable. MCM patients continue to receive medical support at the time of hospital discharge. tion repair, gastroschisis repair, meningomyelocele repair, colostomy, and ventriculoperitoneal shunt. Surgery was independently associated with significant increases ( p ϭ 0.0001, by rank sum) in length of stay and cost within both patient groups (MCM versus non-MCM, data not shown). At discharge, 33% of patients with MCM received ongoing medical support. The most common category of support received was nursing services (31.3%) followed by nutritional support (13.9%). Eleven percent of patients received medical support from more than one category (Table 5) .
Primary Outcomes
DISCUSSION
This study was performed to determine the hospital resource use and postdischarge care requirements of infants with major congenital malformations within a defined geographic referral region. We showed that the population of infants with MCM represent over a quarter of regional NICU admissions, nearly a third of total NICU days, and 40% of total NICU costs. This is consistent with the findings of Gray et al., 5 who found that patients weighing Ͼ2500 gm with congenital anomalies represented 21% of admissions to a perinatal referral center, accrued significantly higher hospital charges and had longer length of stay than other hospitalized infants with birth weights of Ͼ2500 gm. Our study population differed from that in Gray's study in that we did not use birth weight as an inclusion criterion. The malformation group in our study had a significantly greater gestational age and birth weight than the nonmalformation group, which likely reflects the inclusion of extremely low birth weight and other premature patients in the nonmalformation group. We showed that patients with major congenital malformations were more likely to be delivered at a level III hospital than nonmalformation patients. The reasons for this are unclear, although it could be speculated that an increased number of maternal referrals to perinatal centers with level III nurseries occurred due to enhanced prenatal diagnosis of congenital malformations.
A study by Phibbs et al. 6 in 1981 revealed that low birth weight, surgical intervention and assisted ventilation contributed significantly to variation in cost between patient groups. These risk factors were all associated with higher patient costs. Malformation patients evaluated in our study had a higher incidence of surgical intervention during the initial hospitalization, which may have been predictive of increased length of stay and costs over the nonmalformation group. Surgery was associated in both patient groups with statistically significant increases in both length of stay and cost.
In a population-based study that examined discharge status and postneonatal infant deaths, congenital malformations were the second-most frequent cause of death for the initial hospitalization after prematurity and the second-most frequent cause of postneonatal death after sudden infant death syndrome. 7 In a study by Stewart and Hersh 2 of an 11-year trend in neonatal mortality at Kosair Children's Hospital in Louisville, KY, it was found that neonatal mortality due to congenital malformations had not decreased despite a decrease in overall neonatal mortality. These studies suggest that, although technologic and therapeutic advances in perinatal and newborn care have contributed to decreases in neonatal morbidity and mortality, mortality rates in infants with major congenital malformations have not been significantly altered. Our study did not directly address mortality trends over time, although it gave a glimpse of the impact of the population of surviving infants with major congenital malformations on hospital and out-of-hospital resource use.
Owing to the complex nature of the care of infants with major congenital malformations and the lack of therapeutic modalities for this varied population other than corrective surgery and supportive care, these infants will likely continue to be responsible for a significant proportion of neonatal intensive care resource use. The findings of this study have implications for the care of newborns with major congenital malformations in the referral children's hospital setting. Identification of specific predictors of length of stay and cost such as surgical procedures helps to define a subset of the malformation population that is more likely to require rehospitalization and continued outpatient subspecialty visits. This information would be of interest to health-maintenance organizations and third-party payers. In addition to the financial aspects of the ongoing care of these infants, there are ethical and social implications. There are no established instruments measuring the "burden of care" to families caring for their children with malformations at home. Information of this nature is needed to facilitate ethical discussions about quality of life and for families to receive necessary emotional and medical support for their infants. Further research in the area of newborns with malformations is necessary. Their number and impact in the referral NICU is too significant to ignore.
